Correlation Between Apogee Therapeutics, and MusclePharm
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and MusclePharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and MusclePharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and MusclePharm, you can compare the effects of market volatilities on Apogee Therapeutics, and MusclePharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of MusclePharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and MusclePharm.
Diversification Opportunities for Apogee Therapeutics, and MusclePharm
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apogee and MusclePharm is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and MusclePharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MusclePharm and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with MusclePharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MusclePharm has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and MusclePharm go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and MusclePharm
If you would invest (100.00) in MusclePharm on September 1, 2024 and sell it today you would earn a total of 100.00 from holding MusclePharm or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Apogee Therapeutics, Common vs. MusclePharm
Performance |
| Timeline |
| Apogee Therapeutics, |
| MusclePharm |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Apogee Therapeutics, and MusclePharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apogee Therapeutics, and MusclePharm
The main advantage of trading using opposite Apogee Therapeutics, and MusclePharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, MusclePharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MusclePharm will offset losses from the drop in MusclePharm's long position.| Apogee Therapeutics, vs. Cue Biopharma | Apogee Therapeutics, vs. Tff Pharmaceuticals | Apogee Therapeutics, vs. Eliem Therapeutics | Apogee Therapeutics, vs. Inhibrx |
| MusclePharm vs. Chimerix | MusclePharm vs. Apogee Therapeutics, Common | MusclePharm vs. Canlan Ice Sports | MusclePharm vs. United Parks Resorts |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |